Wayne Winegarden
Business & Economics
Empowering Shareholders Will Help Reduce Proxy Advisory Firm’s Undue Influence
Titans of Wall Street have become vocal advocates for environmental, social, and governance (ESG) investing – including leaders of the world’s largest asset managers, banks, and other financial institutions. Less well known proponents, but perhaps even more influential, are the proxy advisory firms ISS and Glass Lewis, who control 97 percent of ...
Business & Economics
Neither The Department Of Defense Nor NASA Should Be Setting U.S. Climate Policy
It should be self-evident that the Department of Defense (DoD), General Services Administration (GSA), and National Aeronautics and Space Administration (NASA) don’t have the authority to set the nation’s climate policy. Yet, this is precisely what these agencies are trying to do. The DOD, GSA, and NASA have issued a joint ...
Commentary
Transparency Is A Necessary First Step Toward A Better Healthcare System
The U.S. Departments of Labor and Health and Human Services has issued a new joint federal rule. Another federal mandate is hardly newsworthy, but one devised under the Trump Administration and eagerly implemented by the Biden Administration is certainly unique. Beyond the politics, the Transparency in Coverage rule, while not ...
California
On brink of recession, Newsom and lawmakers must budget cautiously
Gov. Newsom on Tuesday proposed a roughly $297 billion state budget plan for the 2023-24 fiscal year. In contrast to last year’s nearly $100 billion surplus, the administration projects $29.5 billion in lower than estimated revenues and a $22.5 billion shortfall. The Newsom spending plan does some good things – including paying ...
Drug Pricing
NEW BRIEF: Empowering Providers to Promote Healthcare Innovation
These reforms include: Implementing the insurance reforms discussed in Part 5 that, from a provider perspective, will incentivize the creation of innovative payment models. New payment models create opportunities to better align the incentives of providers and patients. Implementing regulatory reforms that include eliminating certificate of need laws, scope ...
Commentary
An Effective Treatment for Alzheimer’s, But Only if ICER Allows It
Three days before Christmas, the Institute for Clinical & Economic Review (ICER) is scheduled to publish a draft assessment of two promising treatments for Alzheimer’s disease. Unfortunately for the millions of Americans living with this fatal illness, it is likely that ICER will be giving lumps of coal, not gifts, ...
Business & Economics
Activist Investors Are Putting Ideology Before Shareholder Value
Under the leadership of Gary Gensler, the Securities and Exchange Commission (SEC) is empowering activist investors to pursue their preferred politics and social causes at the expense of investors’ interests. According to a November 3, 2021 SEC staff memo Staff will no longer focus on determining the nexus between a policy issue ...
Business & Economics
Governor Newsom’s ESG Errors
California Gov. Gavin Newsom this week released a lengthy commentary defending so-called ESG investing, which he wrote has “proven results.” His defense requires fact checking and context. Environmental, Social and Governance (ESG) is the latest investing trend that claims investors can earn higher returns while also “doing good” on important social issues ...
Blog
Congress Needs to Look Beyond Green Energy
Current U.S. energy policy continues to subsidize uneconomical and inefficient sources of politically preferred energy while punishing the production and generation of reliable and cheap energy sources. As taxpayers, workers, and consumers we are paying a steep price for these irrational policies. Starting with the policies that punish domestic energy ...
Drug Innovation
NEW BRIEF: Promoting Transparency and Competition in the Drug Market
DOWNLOAD THE BRIEF BY WAYNE WINEGARDEN AND CELINE BOOKIN In addition to the reforms to the health insurance system, which will help address the problems of drug affordability, reforms tailored to the pharmaceutical sector are necessary. These reforms should eliminate drug supply chain inefficiencies and include: fostering a ...
Empowering Shareholders Will Help Reduce Proxy Advisory Firm’s Undue Influence
Titans of Wall Street have become vocal advocates for environmental, social, and governance (ESG) investing – including leaders of the world’s largest asset managers, banks, and other financial institutions. Less well known proponents, but perhaps even more influential, are the proxy advisory firms ISS and Glass Lewis, who control 97 percent of ...
Neither The Department Of Defense Nor NASA Should Be Setting U.S. Climate Policy
It should be self-evident that the Department of Defense (DoD), General Services Administration (GSA), and National Aeronautics and Space Administration (NASA) don’t have the authority to set the nation’s climate policy. Yet, this is precisely what these agencies are trying to do. The DOD, GSA, and NASA have issued a joint ...
Transparency Is A Necessary First Step Toward A Better Healthcare System
The U.S. Departments of Labor and Health and Human Services has issued a new joint federal rule. Another federal mandate is hardly newsworthy, but one devised under the Trump Administration and eagerly implemented by the Biden Administration is certainly unique. Beyond the politics, the Transparency in Coverage rule, while not ...
On brink of recession, Newsom and lawmakers must budget cautiously
Gov. Newsom on Tuesday proposed a roughly $297 billion state budget plan for the 2023-24 fiscal year. In contrast to last year’s nearly $100 billion surplus, the administration projects $29.5 billion in lower than estimated revenues and a $22.5 billion shortfall. The Newsom spending plan does some good things – including paying ...
NEW BRIEF: Empowering Providers to Promote Healthcare Innovation
These reforms include: Implementing the insurance reforms discussed in Part 5 that, from a provider perspective, will incentivize the creation of innovative payment models. New payment models create opportunities to better align the incentives of providers and patients. Implementing regulatory reforms that include eliminating certificate of need laws, scope ...
An Effective Treatment for Alzheimer’s, But Only if ICER Allows It
Three days before Christmas, the Institute for Clinical & Economic Review (ICER) is scheduled to publish a draft assessment of two promising treatments for Alzheimer’s disease. Unfortunately for the millions of Americans living with this fatal illness, it is likely that ICER will be giving lumps of coal, not gifts, ...
Activist Investors Are Putting Ideology Before Shareholder Value
Under the leadership of Gary Gensler, the Securities and Exchange Commission (SEC) is empowering activist investors to pursue their preferred politics and social causes at the expense of investors’ interests. According to a November 3, 2021 SEC staff memo Staff will no longer focus on determining the nexus between a policy issue ...
Governor Newsom’s ESG Errors
California Gov. Gavin Newsom this week released a lengthy commentary defending so-called ESG investing, which he wrote has “proven results.” His defense requires fact checking and context. Environmental, Social and Governance (ESG) is the latest investing trend that claims investors can earn higher returns while also “doing good” on important social issues ...
Congress Needs to Look Beyond Green Energy
Current U.S. energy policy continues to subsidize uneconomical and inefficient sources of politically preferred energy while punishing the production and generation of reliable and cheap energy sources. As taxpayers, workers, and consumers we are paying a steep price for these irrational policies. Starting with the policies that punish domestic energy ...
NEW BRIEF: Promoting Transparency and Competition in the Drug Market
DOWNLOAD THE BRIEF BY WAYNE WINEGARDEN AND CELINE BOOKIN In addition to the reforms to the health insurance system, which will help address the problems of drug affordability, reforms tailored to the pharmaceutical sector are necessary. These reforms should eliminate drug supply chain inefficiencies and include: fostering a ...
